GlassScriptPhysician profile
Jasmeet Kaur
NPI 1376004150
$573.59
in general payments reported to CMS, 2019-2025
15 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.54 · 2023: $101 · 2024: $132 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.54 | 2021 | |
| Lilly USA, LLC | $83.43 | 2023-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $65.49 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.30 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Beone Medicines USA, INC. | $46.55 | 2025 | Tevimbra |
| Bayer Healthcare Pharmaceuticals INC. | $44.88 | 2023-2024 | |
| Novo Nordisk INC | $30.84 | 2025 | Rybelsus, Ozempic |
| Abbott Laboratories | $26.95 | 2025 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.08 | 2025 | Caplyta |
| Merck Sharp & Dohme LLC | $20.85 | 2023 | Verquvo, Steglatro, Belsomra |
| Glaxosmithkline, LLC. | $20.22 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.26 | 2024 | Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.11 | 2025 | Trulance |
| Axsome Therapeutics, INC. | $14.92 | 2024 | Auvelity |
| Inari Medical, INC. | $14.17 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmeet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.